292 related articles for article (PubMed ID: 6123591)
1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
[TBL] [Abstract][Full Text] [Related]
2. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
Huidobro F; Huidobro-Toro JP; Miranda H
Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
[TBL] [Abstract][Full Text] [Related]
3. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
[TBL] [Abstract][Full Text] [Related]
4. Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs.
Ho CL; Ko JL; Li CH
Int J Pept Protein Res; 1988 Jul; 32(1):74-8. PubMed ID: 2851563
[TBL] [Abstract][Full Text] [Related]
5. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
Ho CL; Li CH
Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
[TBL] [Abstract][Full Text] [Related]
6. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
Sánchez-Blázquez P; Garzón J; Lee NM
J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
[TBL] [Abstract][Full Text] [Related]
7. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
Oka T; Negishi K
Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
Cox BM; Chavkin C
Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
[No Abstract] [Full Text] [Related]
9. Opioid receptor selectivity of dynorphin gene products.
James IF; Fischli W; Goldstein A
J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the epsilon-type of opioid receptor in the rat vas deferens.
Garzón J; Schulz R; Herz A
Mol Pharmacol; 1985 Jul; 28(1):1-9. PubMed ID: 2991732
[TBL] [Abstract][Full Text] [Related]
11. Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats.
Tseng LF; Towell JF; Fujimoto JM
J Pharmacol Exp Ther; 1986 Apr; 237(1):65-74. PubMed ID: 2420969
[TBL] [Abstract][Full Text] [Related]
12. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
Dean DM; Lemaire S; Livett BG
J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
[TBL] [Abstract][Full Text] [Related]
13. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
Lemaire S; Magnan J; Regoli D
Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
[TBL] [Abstract][Full Text] [Related]
14. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
[TBL] [Abstract][Full Text] [Related]
15. Lack of mixed agonist-antagonist properties of [Gln8-Gly31]-beta h-EP-Gly-Gly-NH2 and [Arg9,19,24,28,29]-beta h-EP in the rat vas deferens neuroeffector junction: studies with naloxone, beta-funaltrexamine and ICI 174,864.
Valenzuela R; Li CH; Huidobro-Toro JP
J Pharm Pharmacol; 1989 Feb; 41(2):92-6. PubMed ID: 2568435
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
Tseng LF; Cheng SS; Fujimoto JM
J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.
Kamikawa Y; Shimo Y
Br J Pharmacol; 1983 Apr; 78(4):693-9. PubMed ID: 6303485
[TBL] [Abstract][Full Text] [Related]
18. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
Chang KJ; Blanchard SG; Cuatrecasas P
Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
[TBL] [Abstract][Full Text] [Related]
19. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
20. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
Schulz R; Wüster M; Herz A
J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
